Академический Документы
Профессиональный Документы
Культура Документы
Chapter 21
Inotropic Drugs
Chronotropic Drugs
Dromotropic Drugs
Heart Failure
Congestive heart failure (CHF), or heart failure (HF), is a condition in which the heart can't pump enough blood to the body's other organs. This can result from narrowed arteries that supply blood to the heart muscle coronary artery disease (CAD) past heart attack, or myocardial infarction (MI), with scar tissue that interferes with the heart muscle's normal work high blood pressure heart valve disease due to past rheumatic fever or other causes primary disease of the heart muscle itself, called cardiomyopathy. heart defects present at birth congenital heart defects. infection of the heart valves and/or heart muscle itself endocarditis and/or myocarditis
CAD
Endocarditis
Heart Failure
As blood flow out of the heart slows, blood returning to the heart through the veins backs up, causing congestion in the tissues. Often swelling (edema) results. Most often there's swelling in the legs and ankles, but it can happen in other parts of the body, too. Sometimes fluid collects in the lungs and interferes with breathing, causing shortness of breath, especially when a person is lying down.
Heart Failure
Often no symptoms at rest Dyspnea (difficulty breathing) and fatigue occur with increased activity Edema of ankles and feet Distention of jugular veins In acute cases pulmonary edema cough and shortness of breath
Pitting Edema
Cardiac Glycosides
Oldest and most effective group of cardiac drugs. Comes from the plant fox glove.
Actions
Digoxin improves the pumping ability of the heart Increases the force of myocardial contraction by inhibiting the Na, K-adenosine triphosphatase, an enzyme in cardiac cell membrane that decreases the movement of sodium out of myocardial cell after contraction. Calcium enter the cell in exchange for sodium. The calcium activates the contractile proteins and increased myocardial contractility.
Administration
Maximum drug action occurs when steady tissue concentration has been achieved takes about 1 week Loading dose or digitalizing dosage will be higher until the therapeutic level has been reached. Dosage 0.75 to 1.5 mg every 6 to 8 hours When adequate levels have been reached than a maintenance dose can be started
Maintenance Dose
Dosing is 0.125 0.5 mg Average dose is 0.25 mg Take daily at same time of day Give with food or after meals
IV digitalizing dose = 0.6 to 1 mg (10 -15 mcg/kg) given at 50% initially and additional fractions given at 4-8 hour intervals. PO adults digitalizing dose 0.75 1.25 mg (10 15 mcg/kg) PO children digitalizing dose 10 to 15 mcg/kg
Nursing Responsibilities
Take apical pulse for one full minute before giving the medication listen for any irregular heart beats Specific guidelines for holding the drug and notifying physician
Adults: apical pulse less than 60 Older child: apical pulse less than 60 Infant or younger child: apical pulse less than 100
Nursing Responsibilities
Notify physician if bradycardia (heart rate less than 60 bpm) or new arrhythmias occur. Assess for peripheral edema and auscultate lunge for rales/crackles. Check kidney function since you want to know they can excrete excess digoxin and avoid build up in body.
Laboratory Values
Electrolyte imbalance: potassium, calcium and magnesium values need to be monitored Hypokalemia (low potassium) Hypomagnesemia (low magnesium) Both can lead to irregular heart rate.
Digoxin Toxicity
Anorexia, nausea, and confusion are symptoms of digoxin toxicity HR below 60 in adults and 100 in infants and small children Digoxin should be discontinued by MD only takes about 1 week for drug to be eliminated from the body.
Evaluation of Effectiveness
Increased urinary output Decreased edema Decreased shortness of breath, dyspnea and crackles Decreased fatigue Improved peripheral pulses, skin color and temperature Serum digoxin levels 0.5 to 2 ng/mL
digoxin Overdose
digoxin immune Fab or DigiFab Therapeutic classification: antidotes Pharmacologic classification: antibody fragments Indications: serious life-threatening over dosage with digoxin. Action: An antibody produced in sheep that binds anti-genetically to unbound digoxin in serum. Therapeutic effect: Binding and subsequent removal of digoxin, preventing toxic effects in overdose.
Antianginal Drugs
Chapter 23
Coronary Arteries
Coronary Arteries
Angina Pectoris
Chest pain occurring when the hearts supply of blood carrying oxygen and energy-rich nutrients is insufficient to meet demands of the heart.
Ischemia
Poor blood flow to an organ Ischemic heart disease = poor blood flow to heart Myocardial infarct = damage done to heart muscle after an ischemic event
Angina
Angina pectoris is a clinical symptoms characterized by episodes of chest pain. There is deficit in myocardial oxygen supply (myocardial ischemia) in relation to myocardial oxygen demand. Pain can be caused by coronary vasospasm
Angina
Angina
Classification of Angina
Class I: ordinary physical activity does not cause angina strenuous activity only. Class II: angina occurs with walking or climbing stairs rapidly or up hill. Class III: marked limitation in ordinary daily activity. Class IV: anginal symptoms may be present at rest.
Antianginal Drugs
Nitrates are used to treat and prevent attack of angina. Only nitrates can be used in the acute treatment of angina pectoris. Calcium channel blockers and beta blockers are used prophylactically or in long-term management of angina.
nitroglycerin
nitroglycerine
nitroglycerine
Action: Increases coronary blood flow by dilating coronary arteries and improving collateral flow to ischemic regions. Decreases left ventricular end-diastolic pressure and left ventricular end-diastolic volume. Reduces myocardial oxygen consumption. Therapeutic effects:
Dosing
Oral dosage is rapidly metabolized in the liver and only small doses reach the systemic circulatory system For more effective absorption drug is given:
Sublingually under the tongue acts in 1 to 3 minutes PO: sustained-released tablet Transdermal ointments applied on hairless area on back, chest or upper arm Patches takes a 40 minutes to an hour to start working
Sublingual Nitroglycerine
Sublingual Administration
Tablet should be held under tongue until dissolved. Avoid eating, drinking, or smoking until tablet is dissolved. Acute anginal attacks:
Advise patient to sit down. Relief should occur in 5 minutes May be repeated every 5 minutes for 3 doses. If no relief call 911.
Administer dose 1 hour before or 2 hours after meal with a full glass of water for faster absorption. Note: Sustained released preparations should be swallowed whole, do not crush, break or chew.
Nitroglycerine Patch
Nitroglycerin Patch
Place the patch on a hairless area of chest or upper arm each day. Move patch to a different place on your body each day to prevent skin irritation. Remove the patch for 8 to 12 hours each night and put on a fresh patch each day. Do not leave on all the time. Remove for defibrillation
Nitroglycerine Ointment
Nitroglycerine Ointment
Comes with paper with a ruled line for measuring the dose Squeeze ointment onto the paper, carefully measuring the amount specified on the prescription label Use the paper to spread ointment in a thin layer on a hair-free area of skin (2 by 3 inches) Keep paper in place with bandage or tape Ointment is applied three or four times a day
Side Effects
Dizziness or light-headedness Flushing of face and neck Increased heart rate Restlessness Rare side effects:
B-adrenergic Blockers
When Used
Decrease energy demands on heart to decrease angina attacks. Block the B receptors on the SA node to slow heart rate Block the harmful release of catecholamines (epinephrine and norepinephrine) Blocks the release of renin a potent vasoconstrictor in the kidney to decrease blood pressure.
Contraindications
Systolic heart failure Systolic cardiac (heart) dysfunction (or systolic heart failure) occurs when the heart muscle doesn't contract with enough force, so there is not enough oxygen-rich blood to be pumped throughout the body.
Contraindications
Conductive disturbances Bronchial asthma Diabetes: blocks hypo-glycemic induced tachycardia. Reduced metal alertness Peripheral vascular disease
Adverse Effects
Decrease in HR blow the 60 bpm Decreased cardiac output Bronchocontriction in patients with asthma or COPD. Cardiac rhythm problems due to decreased SA or AV node conduction Hypo or hyperglycemia
Action
Prevents calcium from entering into contraction process of the heart thus promoting smooth muscle relaxation and coronary artery dilation. Increased blood flow to ischemic heart Useful in treating dysrhythmias
Indications
Supraventricular Tachycardia
Supraventricular tachycardia is one type of heart rhythm disorder. Tachycardia's are rhythm disorders in which the heart beats faster than normal. Supraventricular means "above the ventricles," in other words, originating from the atria, the upper chambers of the heart. Supraventricular tachycardia, then, is a rapid heartbeat originating in the atria. These AV node may be involved.
May not be as effective in controlling exercise induced elevation of heart rate or blood pressure.
Contraindications
Bradycardia Pacemaker
Hypotension
Adverse Effects
Cardiovascular:
Vasodilators
Action: works directly on arteriolar and venous muscles to cause relaxation. Very useful in managing hypertensive emergencies. Blood pressure needs to be brought down slowly.
Vasodilators
Intravenous (IV) diazoxide and sodium nitroprusside are useful in managing hypertensive emergencies.
Nursing Assessment
Nursing Assessment
Client will return to baseline activities Client will report improved energy. Blood pressure reading will be lowered with the goal to bring back to normal levels.